Fig. 4From: A MgAl-LDH-CuS nanosheet-based thermo-responsive composite hydrogel with nir-responsive angiogenesis inhibitor releasing capability for multimode starvation therapy(a) Schematic illustration of experimental apparatus for ex vivo vascular occlusion test. (b) DMEM volume passing the ex vivo blood vessels before (left) and after (right) gelation of SOR@LDH-CuS/P. (c) MTT results of 4T1, Hela and HepG2 cells incubated with LDH-CuS/P hydrogels containing various concentrations of LDH-CuS. (d) Cell viability of HepG2 cells after different treatments: (1) control, (2) NIR, (3) LDH-CuS/P, (4) LDH-CuS/P + NIR, (5) SOR@LDH-CuS/P, (6) SOR@LDH-CuS/P + NIR. (e) Calcein-AM/PI staining images and (f) apoptosis analysis by flow cytometry after different treatmentsBack to article page